Publications
Detailed Information
Effects of adding luteinizing hormone activity to gonadotropin releasing hormone antagonist protocols may differ according to age
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong Jin | - |
dc.contributor.author | Ku, Seung-Yup | - |
dc.contributor.author | Jee, Byung Chul | - |
dc.contributor.author | Suh, Chang Suk | - |
dc.contributor.author | Choi, Young Min | - |
dc.contributor.author | Moon, Shin Yong | - |
dc.contributor.author | Kim, Jung Gu | - |
dc.contributor.author | Kim, Seok Hyun | - |
dc.date.accessioned | 2012-06-05T00:55:01Z | - |
dc.date.available | 2012-06-05T00:55:01Z | - |
dc.date.issued | 2010-04 | - |
dc.identifier.citation | GYNECOLOGICAL ENDOCRINOLOGY; Vol.26 4; 256-260 | ko_KR |
dc.identifier.issn | 0951-3590 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76822 | - |
dc.description.abstract | Objective. In spite of previous reports on the beneficial effects of adding exogenous luteinizing hormone (LH) activity
to gonadotropin releasing hormone (GnRH) antagonist protocols for conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), these effects in various age groups are still controversial. This study was performed to evaluate the clinical efficacy of adding LH activity to GnRH antagonist protocols according to patients age. Methods. In this medical record review, responses to controlled ovarian hyperstimulation (COH) and IVF/ICSI outcomes were compared between follicle stimulating hormone (FSH) alone and FSH supplemented with LH activity groups in women < 35 years (n = 135) and those > 35 years (n = 97), respectively. Results. Estradiol level on hCG day in LH-added group was higher (2.150.6 +/- 1.345.1 pg/ml vs. 1.606.2 +/- 994.6 pg/ml, P = 0.011) in women < 35 years, while it did not differ in those > 35 years. Less oocytes were retrieved in LH-added group of women > 35 years (8.1 +/- 6.5 vs. 5.7 +/- 3.0, P = 0.013), however, this figure did not differ in those < 35 years. Regardless of age, the clinical pregnancy rates were not different between the two groups. Conclusions. Supplementation of exogenous LH activity to GnRH antagonist protocols affects the COH outcomes. These LH-adding effects may vary according to patient`s age. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | INFORMA HEALTHCARE | ko_KR |
dc.subject | LH | ko_KR |
dc.subject | GnRH antagonist | ko_KR |
dc.subject | IVF | ko_KR |
dc.subject | ICSI | ko_KR |
dc.title | Effects of adding luteinizing hormone activity to gonadotropin releasing hormone antagonist protocols may differ according to age | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김용진 | - |
dc.contributor.AlternativeAuthor | 구승엽 | - |
dc.contributor.AlternativeAuthor | 조병철 | - |
dc.contributor.AlternativeAuthor | 서창석 | - |
dc.contributor.AlternativeAuthor | 김석현 | - |
dc.contributor.AlternativeAuthor | 최영민 | - |
dc.contributor.AlternativeAuthor | 김정구 | - |
dc.contributor.AlternativeAuthor | 문신용 | - |
dc.identifier.doi | 10.3109/09513590903247865 | - |
dc.citation.journaltitle | GYNECOLOGICAL ENDOCRINOLOGY | - |
dc.description.citedreference | KOVACS P, 2009, FERTIL STERIL | - |
dc.description.citedreference | Lee JR, 2008, FERTIL STERIL, V89, P860, DOI 10.1016/j.fertnstert.2007.04.010 | - |
dc.description.citedreference | Weghofer A, 2008, HUM REPROD, V23, P499, DOI 10.1093/humrep/dem412 | - |
dc.description.citedreference | WEGHOFER A, 2008, FERTIL STERIL | - |
dc.description.citedreference | Kolibianakis EM, 2007, HUM REPROD UPDATE, V13, P445, DOI 10.1093/humupd/dmm008 | - |
dc.description.citedreference | Martin-Johnston M, 2007, REPROD BIOMED ONLINE, V15, P161 | - |
dc.description.citedreference | Moon SY, 2007, J OBSTET GYNAECOL RE, V33, P305, DOI 10.1111/j.1447-0756.2007.00529.x | - |
dc.description.citedreference | Ruvolo G, 2007, FERTIL STERIL, V87, P542, DOI 10.1016/j.fertnstert.2006.06.059 | - |
dc.description.citedreference | Mochtar MH, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005070.pub2 | - |
dc.description.citedreference | Baruffi R, 2007, REPROD BIOMED ONLINE, V14, P14 | - |
dc.description.citedreference | Levi-Setti PE, 2006, EUR J OBSTET GYN R B, V126, P212, DOI 10.1016/j.ejogrb.2005.11.023 | - |
dc.description.citedreference | Kolibianakis EM, 2006, HUM REPROD UPDATE, V12, P3, DOI 10.1093/humupd/dmi030 | - |
dc.description.citedreference | Ku SY, 2005, GYNECOL ENDOCRINOL, V21, P227, DOI 10.1080/09513590500282125 | - |
dc.description.citedreference | Chung K, 2005, FERTIL STERIL, V84, P313, DOI 10.1016/j.fertnstert.2005.02.028 | - |
dc.description.citedreference | Griesinger G, 2005, HUM REPROD, V20, P1200, DOI 10.1093/humrep/deh741 | - |
dc.description.citedreference | SPEROFF L, 2005, CLIN GYNECOLOGIC END | - |
dc.description.citedreference | Sauer MV, 2004, REPROD BIOMED ONLINE, V9, P487 | - |
dc.description.citedreference | Cedrin-Durnerin I, 2004, HUM REPROD, V19, P1979, DOI 10.1093/humrep/deh369 | - |
dc.description.citedreference | Acevedo B, 2004, FERTIL STERIL, V82, P343, DOI 10.1016/j.fertnstert.2004.03.020 | - |
dc.description.citedreference | Ku SY, 2003, EUR J OBSTET GYN R B, V109, P55, DOI 10.1016/S0301-2115(02)00476-1 | - |
dc.description.citedreference | LUDWIG M, 2003, TREAT ENDOCRINOL, V2, P305 | - |
dc.description.citedreference | 1998, J CLIN ENDOCRINOL ME, V83, P1507 | - |
dc.description.citedreference | VEECK LL, 1992, CURR OPIN OBSTET GYN, V4, P702 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.